Technical: Ajaya Bio plans Series A to advance autoimmune treatment and grow in Philadelphia
Ajaya Bio plans Series A to advance autoimmune treatment and grow in Philadelphia
alleywatch.com: Inductive Bio Secures $25M Series A to Transform Drug Discovery with its Collaborative AI Platform
Inductive Bio Secures $25M Series A to Transform Drug Discovery with its Collaborative AI Platform
Morningstar: Ecovia Bio Closes Series B Funding Round Led by Pointe Angels to Expand Manufacturing Capacity
Ecovia Bio Closes Series B Funding Round Led by Pointe Angels to Expand Manufacturing Capacity
Yahoo Finance: VST BIO Corporation Announces Series A Financing to Advance VB-001 and Adds William Sessa to Board of Directors
SAN DIEGO, /PRNewswire/ -- VST BIO Corporation ("VST BIO"), a biotechnology company developing stroke therapeutics, announces the closing of its Series A financing, led by Coefficient ...
VST BIO Corporation Announces Series A Financing to Advance VB-001 and Adds William Sessa to Board of Directors
Business Wire: Akamis Bio Announces $60 Million in Funding Linked to Series A Prime Financing and New Strategic Partnership
Akamis Bio Announces $60 Million in Funding Linked to Series A Prime Financing and New Strategic Partnership
Business Wire: Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery
Morningstar: Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio
Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio